Home › Funds › CONGRESS ASSET MANAGEMENT CO › LGND

CONGRESS ASSET MANAGEMENT CO position in LGND

LIGAND PHARMACEUTICALS INC · Health Care

CONGRESS ASSET MANAGEMENT CO reported holding 658,556 shares of LGND (LIGAND PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$205.7M, representing 1.34% of its reported portfolio and ranking #8 among its reported holdings. CONGRESS ASSET MANAGEMENT CO has disclosed LGND holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)658.56K sh
Reported value held$205.71M
Portfolio Weight1.34%
First reportedQ2 2024
Last changeHold
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How CONGRESS ASSET MANAGEMENT CO's LGND position evolved

CONGRESS ASSET MANAGEMENT CO first disclosed a stake in LGND in Q2 2024 at 586,624 shares (US$49.4M). The position peaked in Q2 2026 at 659,911 shares, worth US$208.6M. Across 10 filings, CONGRESS ASSET MANAGEMENT CO increased the stake 7 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 658,556 shares valued at US$205.7M. Notable position changes include a 28% trim in Q4 2025 (shares rose 6% over the following quarter), a 31% increase in Q2 2026 (shares fell 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 586.62K $49.43M New
Q3 2024 604.04K $60.46M Add
Q4 2024 621.48K $66.59M Add
Q1 2025 642.71K $67.57M Add
Q2 2025 647.94K $73.66M Add
Q3 2025 667.31K $118.21M Add
Q4 2025 480.06K $90.77M Reduce
Q1 2026 504.64K $100.75M Add
Q2 2026 659.91K $208.59M Add
Q3 2026 658.56K $205.71M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LGND and 13F data

LGND (LIGAND PHARMACEUTICALS INC) is a Health Care company. 57 other funds we track also report a position in LGND — the largest reported positions include Chicago Capital, LLC (US$172.2M), Stephens Investment Management Group LLC (US$150.3M), RICE HALL JAMES & ASSOCIATES, LLC (US$85.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LGND

All LGND fund holders →

FAQ

How long has CONGRESS ASSET MANAGEMENT CO held LGND?

CONGRESS ASSET MANAGEMENT CO has disclosed LGND holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is CONGRESS ASSET MANAGEMENT CO's current position in LGND?

As of Q3 2026, CONGRESS ASSET MANAGEMENT CO holds 658.56K shares of LGND (LIGAND PHARMACEUTICALS INC), valued at $205.71M, representing 1.34% of its reported portfolio and ranking #8.

Has CONGRESS ASSET MANAGEMENT CO been buying or selling LGND?

In the latest 13F filing (Q3 2026), CONGRESS ASSET MANAGEMENT CO held unchanged its position in LGND. The position peaked in Q2 2026 at 659.91K shares.

Which other funds hold LGND?

Other major institutional holders of LGND include Chicago Capital, LLC, Stephens Investment Management Group LLC, RICE HALL JAMES & ASSOCIATES, LLC, among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.